Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
5 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
A prospective observational study of real-world treatment and outcome in secondary CNS lymphoma.
Eur J Cancer. 2024 Jan;196:113436. doi: 10.1016/j.ejca.2023.113436. Epub 2023 Nov 14.
Eur J Cancer. 2024.
PMID: 38008033
Review.
Human acute myeloid leukemia CD34+CD38- stem cells are susceptible to allorecognition and lysis by single KIR-expressing natural killer cells.
Langenkamp U, Siegler U, Jörger S, Diermayr S, Gratwohl A, Kalberer CP, Wodnar-Filipowicz A.
Langenkamp U, et al.
Haematologica. 2009 Nov;94(11):1590-4. doi: 10.3324/haematol.2009.005967. Epub 2009 Jul 16.
Haematologica. 2009.
PMID: 19608675
Free PMC article.
Item in Clipboard
NKG2D ligand expression in AML increases in response to HDAC inhibitor valproic acid and contributes to allorecognition by NK-cell lines with single KIR-HLA class I specificities.
Diermayr S, Himmelreich H, Durovic B, Mathys-Schneeberger A, Siegler U, Langenkamp U, Hofsteenge J, Gratwohl A, Tichelli A, Paluszewska M, Wiktor-Jedrzejczak W, Kalberer CP, Wodnar-Filipowicz A.
Diermayr S, et al. Among authors: langenkamp u.
Blood. 2008 Feb 1;111(3):1428-36. doi: 10.1182/blood-2007-07-101311. Epub 2007 Nov 9.
Blood. 2008.
PMID: 17993609
Free article.
Item in Clipboard
Differentiation-promoting drugs up-regulate NKG2D ligand expression and enhance the susceptibility of acute myeloid leukemia cells to natural killer cell-mediated lysis.
Rohner A, Langenkamp U, Siegler U, Kalberer CP, Wodnar-Filipowicz A.
Rohner A, et al. Among authors: langenkamp u.
Leuk Res. 2007 Oct;31(10):1393-402. doi: 10.1016/j.leukres.2007.02.020. Epub 2007 Mar 27.
Leuk Res. 2007.
PMID: 17391757
Item in Clipboard
Beta-(1-->3)-D-glucan modulates DNA binding of nuclear factors kappaB, AT and IL-6 leading to an anti-inflammatory shift of the IL-1beta/IL-1 receptor antagonist ratio.
Luhm J, Langenkamp U, Hensel J, Frohn C, Brand JM, Hennig H, Rink L, Koritke P, Wittkopf N, Williams DL, Mueller A.
Luhm J, et al. Among authors: langenkamp u.
BMC Immunol. 2006 Mar 22;7:5. doi: 10.1186/1471-2172-7-5.
BMC Immunol. 2006.
PMID: 16553947
Free PMC article.
Item in Clipboard
Cite
Cite